The European Society for Medical Oncology (ESMO) recently launched the inaugural Congress on Artificial Intelligence and Digital Oncology, taking place in Berlin this week, November 12-14, 2025. With over 1100 participants scheduled to attend, the conference program will include discussions of:
- Multimodal AI for clinical decision support, showcasing applications in molecular tumour boards and real-world data integration.
- AI-based biomarkers for precision oncology, featuring discussions on validation frameworks and predictive modelling, including the announcement of the imminent publication of the ESMO Basic Requirements for AI-based Biomarkers in Oncology (EBAI) framework
- Generative AI and large language models, with keynote lectures featuring speakers from Google DeepMind and Harvard Medical School.
- Digital health in practice, exploring wearable technologies, remote monitoring, decentralised trials.
- Ethics, regulation, and patient perspectives, addressing trust, explainability and the societal implications of AI in oncology.
To learn more about this conference, click here.
No comments:
Post a Comment